Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis

36Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Purpose: To conduct a systematic review of included studies assessing the association of GP210 and SP100 with the risk of primary biliary cirrhosis (PBC) using meta-analysis. Methods: Five databases, the Cochrane Library, MEDLINE, VIP, CNKI, WANFANG were used to detect the role of GP210 and SP100 in diagnosis of PBC. Approximately 13,000 participants from several countries were included in this analysis. Meta-DiSc statistical software was used for analysis. Results: 25 studies on GP210 and 21 studies on SP100 were included in the meta-analysis. The DOR, sensitivity, specificity of GP210 in diagnosis of PBC were 24.854 (11.957-51.660), 0.272 (0.257-0.288), 0.985 (0.982-0.988), respectively, and they were 9.133 (4.739-17.600), 0.231 (0.213-0.249), 0.977 (0.973-0.981) for SP100. Conclusion: Our meta-analysis indicated both GP210 and SP100 had high specificity but low sensitivity in diagnosis of PBC. © 2014 Hu et al.

Cite

CITATION STYLE

APA

Hu, S. L., Zhao, F. R., Hu, Q., & Chen, W. X. (2014). Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis. PLoS ONE, 9(7). https://doi.org/10.1371/journal.pone.0101916

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free